Octadecanamide,N-[(1S,2R,3E)-1-[[[O-b-D-galactopyranosyl-(1®3)-O-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)-O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl-(2®3)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-

Product Information
Product Number: AX-AGO2
Product Name: Octadecanamide,N-[(1S,2R,3E)-1-[[[O-b-D-galactopyranosyl-(1®3)-O-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)-O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl-(2®3)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
CAS: 131129-98-1
MW: 0
Synonyms: Octadecanamide,N-[(1S,2R,3E)-1-[[[O-b-D-galactopyranosyl-(1®3)-O-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)-O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl-(2®3)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-(9CI); Octadecanamide, N-[1-[[[O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl]-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-,[R-[R*,S*-(E)]]-; AGF 44; Mipragoside; Octadecanamide,N-[(1S,2R,3E)-1-[[[O-[N-acetyl-1-(1-methylethyl)-a-neuraminosyl]-(2®3)-O-[O-b-D-galactopyranosyl-(1®3)-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl-(1®4)]-O-b-D-galactopyranosyl-(1®4)-b-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecenyl]-
EINECS:
Density: 1.32g/cm3
Melting Point:
Boiling Point: 1506.8°Cat760mmHg
Flash Point: 865.1°C
Solubility:
Risk Codes:
Transport Information::